A multicenter phase II clinical study of oxaliplatin, folinic acid, and 5-fluorouracil combination chemotherapy as second-line treatment for advanced colorectal cancer: a Japanese experience.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples